Telo Genomics (TSXV:TELO) Beginning Cash Position : C$1.98 Mil (As of Dec. 2023)

View and export this data going back to 2012. Start your Free Trial

What is Telo Genomics Beginning Cash Position?

Telo Genomics's Beginning Cash Position for the quarter that ended in Dec. 2023 was C$1.98 Mil.

Telo Genomics's quarterly Beginning Cash Position declined from Jun. 2023 (C$3.35 Mil) to Sep. 2023 (C$2.67 Mil) and declined from Sep. 2023 (C$2.67 Mil) to Dec. 2023 (C$1.98 Mil).

Telo Genomics's annual Beginning Cash Position increased from Jun. 2021 (C$0.92 Mil) to Jun. 2022 (C$3.64 Mil) but then declined from Jun. 2022 (C$3.64 Mil) to Jun. 2023 (C$2.69 Mil).

Telo Genomics Beginning Cash Position Historical Data

The historical data trend for Telo Genomics's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Telo Genomics Beginning Cash Position Chart

Telo Genomics Annual Data

Trend

Dec13

Dec14

Dec15

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Beginning Cash Position

Get a 7-Day Free Trial

0.07

0.02

0.92

3.64

2.69

Telo Genomics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Beginning Cash Position	Get a 7-Day Free Trial															2.13	1.42	3.35	2.67	1.98

Telo Genomics Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Telo Genomics Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Telo Genomics's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Telo Genomics (TSXV:TELO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Telo Genomics Corp (TSXV:TELO) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

TDSGF:USA 3D0A:Germany

Address

101 College Street, Suite 200, MaRS Centre, South Tower, Toronto, ON, CAN, M5G 1L7

Website

https://www.telodx.com

Telo Genomics Corp is a personalized medicine company. The company through its wholly-owned subsidiary is engaged in the development and commercialization of diagnostic and prognostic products. The company is developing diagnostic and prognostic products for cancer and neurological disorders.

Telo Genomics (TSXV:TELO) Headlines

From GuruFocus

UPDATE -- Telomir Pharmaceuticals Announces Collaboration with Argenta to Study Osteoarthritis in Canines

By GlobeNewswire • 03-29-2024